Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

NCT06650423 · clinicaltrials.gov ↗

RECRUITING

Status

319

Enrollment

OTHER

Sponsor class

Conditions

Early Breast Cancer
Hormone Receptor Positive Tumor
HER2-negative Breast Cancer

Sponsor

Institute of Oncology Ljubljana

Collaborators

[object Object]